<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>58</patient-age><report-id>US-PFIZER INC-2012318572</report-id><gender>female</gender><reactions><reaction>Scheduled for a gall bladder surgery on 17Dec2012</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>Premarin</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Hormone replacement therapy</indication></indications><patient-age>58</patient-age><outcomes/><country>United States</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>psur</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4254111_P31</messagenumb>
		<messagesenderidentifier>PFIZERINC</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151548</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>US-PFIZER INC-2012318572</safetyreportid>
		<primarysourcecountry>US</primarysourcecountry>
		<occurcountry>US</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-12-14</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-22</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>2</fulfillexpeditecriteria>
		<companynumb>US-PFIZER INC-2012318572</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportertitle>Dr.</reportertitle>
			<reportergivename>Mary</reportergivename>
			<reportermiddlename>A</reportermiddlename>
			<reporterfamilyname>Shepard</reporterfamilyname>
			<reporterorganization>Orchards Medical Office</reporterorganization>
			<reporterstreet>7101 NE 137 Ave</reporterstreet>
			<reportercity>Vancouver</reportercity>
			<reporterstate>WA</reporterstate>
			<reporterpostcode>98682-4903</reporterpostcode>
			<reportercountry>US</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>US</reportercountry>
			<qualification code="5">Consumer or non-health professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>PFIZERINC</senderorganization>
			<senderfamilyname>Head Drug Safety Surveillance</senderfamilyname>
			<senderstreetaddress>150 East 42nd Street</senderstreetaddress>
			<sendercity>New York</sendercity>
			<senderstate>New York</senderstate>
			<senderpostcode>10017</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>2127335544</sendertel>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receivertitle>Mr</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20785</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receivertelcountrycode>001</receivertelcountrycode>
			<receiverfax>3019183134</receiverfax>
			<receiverfaxcountrycode>001</receiverfaxcountrycode>
		</receiver>
		<patient>
			<patientinitial>PRIVACY</patientinitial>
			<patientonsetage>58</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientweight>43.1</patientweight>
			<patientheight>157</patientheight>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Trigeminal neuralgia</patientepisodename>
				<patientmedicalcomment>Trigeminal neuralgia attack due to which she had 4 unspecified procedures and 5 brain surgeries</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Brain injury</patientepisodename>
				<patientmedicalstartdateformat>602</patientmedicalstartdateformat>
				<patientmedicalstartdate>1999</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
				<patientmedicalcomment>due to which she put on disability</patientmedicalcomment>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Hysterectomy</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Scheduled for a gall bladder surgery on 17Dec2012</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Gallbladder disorder</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gallbladder disorder</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>Premarin</medicinalproduct>
				<obtaindrugcountry>US</obtaindrugcountry>
				<drugauthorizationnumb>4-782</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Pfizer, Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>.625</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>1</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>0.625 mg, 1x/day</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Hormone replacement therapy</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<activesubstance>
					<activesubstancename>ESTROGENS CONJUGATED</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gallbladder disorder</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gallbladder disorder</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>N/A</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>This is a spontaneous report from a non clinical study program Pfizer Helpful Answers, information received from a contactable consumer and contactable <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>.This 58-year old female patient of unspecified ethnicity reported that she started taking <Semaphore x="544802" class="Medicine - Estrogens - Dose" value="0.625mg" score="0.74" ID=""><Semaphore x="545141" class="Medicine" value="Estrogens" score="0.87" ID="267891">estrogens </Semaphore>conjugated (<Semaphore x="1082344" class="Medicine - Premarin - Dose" value="0.625mg" score="0.49" ID=""><Semaphore x="1082373" class="Medicine" value="Premarin" score="0.49" ID="241366">PREMARIN</Semaphore>) <Semaphore x="2339906772795393" class="Medicine - Estrogens - Dose" value="0.625mg" score="0.74" ID="">0.625mg </Semaphore></Semaphore></Semaphore>
    <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore>tablets once a day as her <Semaphore x="2676938" class="AnatomicStructure" value="Uterus" score="1.00" ID="C12405">uterus </Semaphore>was removed on an unknown date. Relevant medical history included <Semaphore x="3288633" class="MedDRA LLT" value="Trigeminal neuralgia" score="1.00" ID="10044652">trigeminal <Semaphore x="2302717" class="Disease or Finding" value="Neuralgia" score="1.00" ID="C79695">neuralgia </Semaphore></Semaphore>in four <Semaphore x="2294741" class="Disease or Finding" value="Nerve Paralysis" score="1.00" ID="C27036">nerves </Semaphore>and she had a <Semaphore x="3288633" class="MedDRA LLT" value="Trigeminal neuralgia" score="1.00" ID="10044652">trigeminal <Semaphore x="2302717" class="Disease or Finding" value="Neuralgia" score="1.00" ID="C79695">neuralgia </Semaphore></Semaphore>attack on an unknown date due to which she had four unspecified <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">procedures </Semaphore>and five <Semaphore x="1627096" class="Disease or Finding" value="Brain Injury" score="1.00" ID="C50440">brain <Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgeries</Semaphore><Semaphore x="1627096" class="Disease or Finding" value="Brain Injury" score="1.00" ID="C50440">, brain injury </Semaphore></Semaphore>in 1999 due to which she put on <Semaphore x="2909520" class="MedDRA LLT" value="Disability" score="1.00" ID="10013050">disability </Semaphore>and it was unknown whether these conditions were ongoing at the time of this report, in <Semaphore x="1433842" class="Disease or Finding" value="Addiction" score="1.00" ID="C3479">addition </Semaphore>her <Semaphore x="2676938" class="AnatomicStructure" value="Uterus" score="1.00" ID="C12405">uterus </Semaphore>was removed. Relevant concomitant medications included unspecified medications and she was still taking all the concomitant medications. On an unknown date, while on <Semaphore x="544802" class="Medicine - Estrogens - Dose" value="0.625mg" score="0.74" ID=""><Semaphore x="545141" class="Medicine" value="Estrogens" score="0.87" ID="267891">estrogens </Semaphore>conjugated <Semaphore x="2339906772795393" class="Medicine - Estrogens - Dose" value="0.625mg" score="0.74" ID="">0.625mg </Semaphore></Semaphore><Semaphore x="2340632622268417" class="Medicine - Estrogens - Frequency" value="once" score="0.49" ID="">once </Semaphore>a day, she was scheduled for a <Semaphore x="1954692" class="AnatomicStructure" value="Gallbladder" score="1.00" ID="C12377">gall bladder </Semaphore><Semaphore x="2065652" class="Procedure" value="Intervention or Procedure" score="1.00" ID="C25218">surgery </Semaphore>on 17Dec2012. Relevant laboratory data was none. At the time of this report it was unknown whether she was taking <Semaphore x="545141" class="Medicine" value="Estrogens" score="0.87" ID="267891">estrogens </Semaphore>conjugated and the clinical <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the event was unknown.Additionally, a contactable <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>stated that she/he was informed by patient regarding the <Semaphore x="2724216" class="MedDRA LLT" value="Adverse event" score="1.00" ID="10060933">adverse event </Semaphore>with the use of the product, and she/he confirmed occurrence of event.Follow up (22Jan2013): New information received from the contactable <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>included communication between patient and <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>and confirmation of occurrences.Follow up attempts completed. No further information expected.</narrativeincludeclinical>
				<sendercomment>On the basis of the available information, a possible causal relationship between the onset of the reported event and treatment with conjugated estrogens cannot be ruled out.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>